Physician profile
Derik Scribner
NPI 1205221991
$4,487.18
in general payments reported to CMS, 2019-2025
29 companies · $368 in 2025
The $368 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $822 · 2020: $807 · 2021: $664 · 2022: $1,121 · 2023: $568 · 2024: $137 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,430.39 | 2020-2025 | Artisan |
| Medtronic USA, INC. | $822.38 | 2019 | |
| Abbvie INC. | $528.78 | 2020-2025 | Botox |
| Allergan, INC. | $267.97 | 2020-2022 | |
| Collegium Pharmaceutical, INC. | $199.22 | 2020-2023 | Belbuca |
| Nevro Corp. | $185.40 | 2021-2023 | Senza |
| Radius Health, INC. | $120.44 | 2021-2023 | Tymlos |
| Ipsen Biopharmaceuticals, INC | $118.16 | 2023-2025 | Dysport |
| Merz Pharmaceuticals, LLC | $113.32 | 2021-2025 | Xeomin |
| Pfizer INC. | $91.06 | 2021-2025 | |
| Averitas Pharma INC. | $90.00 | 2023-2025 | Qutenza |
| Biohaven Pharmaceutical Holding Company LTD. | $85.03 | 2022 | |
| Abbott Laboratories | $71.28 | 2024-2025 | Proclaim |
| Alexion Pharmaceuticals, INC. | $41.39 | 2022 | |
| Axsome Therapeutics, INC. | $32.42 | 2023 | Sunosi |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $31.69 | 2022 | |
| Amgen INC. | $30.56 | 2021 | |
| Glaxosmithkline, LLC. | $24.30 | 2021-2022 | |
| Stryker Corporation | $23.17 | 2022 | |
| Trice Medical, INC. | $22.16 | 2023 | |
| Si-Bone, INC. | $22.09 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.35 | 2025 | |
| Grt US Holding, INC. | $21.16 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.79 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $16.58 | 2021 | |
| Spr Therapeutics, INC | $16.53 | 2025 | Sprint Pns System |
| Avanir Pharmaceuticals, INC. | $16.38 | 2021 | |
| Mdd US Operations, LLC | $14.80 | 2020 | |
| Janssen Biotech, INC. | $11.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derik Scribner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.